Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions,

BeiBei Luo1, Jayanthi Repalli, Al-Motassem Yousef

  • 1Department of Pharmaceutical Sciences, University of South Carolina, Columbia, South Carolina 29208, USA.

Insights

Inactive-stabilized thymidylate synthase (TS) mutants exhibit altered structures, substrate responses, and phosphorylation patterns. This suggests a physiological role for TS conformational switching in cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Thymidylate synthase (TS) is a crucial cancer target.
  • TS exhibits conformational switching between active and inactive states.
  • Mutant hTS proteins (M190K, A191K) are stabilized in inactive conformations.

Purpose of the Study:

  • Investigate structural and functional differences of inactive-stabilized hTS mutants.
  • Determine the impact of conformational stabilization on protein phosphorylation.
  • Explore the physiological relevance of TS conformational switching.

Main Methods:

  • Intrinsic fluorescence and circular dichroism spectroscopy.
  • Enzyme kinetics and inhibitor potency assays.
  • Casein kinase 2 (CK2) phosphorylation studies.
  • Temperature dependence analysis of catalysis.

Main Results:

  • Mutants M190K and A191K display unique structural and thermal properties compared to wild-type hTS.
  • Substrate dUMP affects A191K structure but not M190K.
  • M190K shows high CK2 phosphorylation, independent of dUMP.
  • A191K exhibits altered catalytic activity, inhibitor response, and substrate interaction.
  • CK2 phosphorylation of hTS is selective for the inactive conformation.

Conclusions:

  • Inactive-stabilized hTS mutants exhibit distinct biochemical and biophysical characteristics.
  • Protein phosphorylation by CK2 is conformation-specific, highlighting physiological relevance.
  • Conformational switching of TS is a key factor in its biological function and potential therapeutic targeting.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...